BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23155750)

  • 1. [MODY diabetes--a monogenic developmental and functional disturbance of pancreatic beta cells].
    Miettinen PJ; Tuomi T
    Duodecim; 2012; 128(19):1989-98. PubMed ID: 23155750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Glucokinase gene abnormalities in maturity-onset diabetes of the young (MODY) and late-onset NIDDM].
    Odawara M
    Nihon Rinsho; 1994 Oct; 52(10):2580-6. PubMed ID: 7983782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maturity-onset diabetes of the young: from clinical description to molecular genetic characterization.
    Owen K; Hattersley AT
    Best Pract Res Clin Endocrinol Metab; 2001 Sep; 15(3):309-23. PubMed ID: 11554773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HDL cholesterol as a diagnostic tool for clinical differentiation of GCK-MODY from HNF1A-MODY and type 1 diabetes in children and young adults.
    Fendler W; Borowiec M; Antosik K; Szadkowska A; Deja G; Jarosz-Chobot P; Mysliwiec M; Wyka K; Pietrzak I; Skupien J; Malecki MT; Mlynarski W
    Clin Endocrinol (Oxf); 2011 Sep; 75(3):321-7. PubMed ID: 21521320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy.
    Gloyn AL
    Hum Mutat; 2003 Nov; 22(5):353-62. PubMed ID: 14517946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The glucokinase mutation p.T206P is common among MODY patients of Jewish Ashkenazi descent.
    Gozlan Y; Tenenbaum A; Shalitin S; Lebenthal Y; Oron T; Cohen O; Phillip M; Gat-Yablonski G
    Pediatr Diabetes; 2012 Sep; 13(6):e14-21. PubMed ID: 21978167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GCK and HNF1A mutations in Canadian families with maturity onset diabetes of the young (MODY).
    Cao H; Shorey S; Robinson J; Metzger DL; Stewart L; Cummings E; Hegele RA
    Hum Mutat; 2002 Dec; 20(6):478-9. PubMed ID: 12442280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus.
    Froguel P; Zouali H; Vionnet N; Velho G; Vaxillaire M; Sun F; Lesage S; Stoffel M; Takeda J; Passa P
    N Engl J Med; 1993 Mar; 328(10):697-702. PubMed ID: 8433729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucokinase mutations in young children with hyperglycemia.
    Codner E; Deng L; Pérez-Bravo F; Román R; Lanzano P; Cassorla F; Chung WK
    Diabetes Metab Res Rev; 2006; 22(5):348-55. PubMed ID: 16444761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic screening of MODY2/GCK mutations in the Norwegian MODY Registry.
    Sagen JV; Bjørkhaug L; Molnes J; Raeder H; Grevle L; Søvik O; Molven A; Njølstad PR
    Pediatr Diabetes; 2008 Oct; 9(5):442-9. PubMed ID: 18399931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic and pathomorphological characteristics of a novel mutant mouse model for maturity-onset diabetes of the young type 2 (MODY 2).
    van Bürck L; Blutke A; Kautz S; Rathkolb B; Klaften M; Wagner S; Kemter E; Hrabé de Angelis M; Wolf E; Aigner B; Wanke R; Herbach N
    Am J Physiol Endocrinol Metab; 2010 Mar; 298(3):E512-23. PubMed ID: 19952346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel GCK and HNF1A/TCF1 mutations and polymorphisms in German families with maturity-onset diabetes of the young (MODY).
    Toaima D; Näke A; Wendenburg J; Praedicow K; Rohayem J; Engel K; Galler A; Gahr M; Lee-Kirsch MA
    Hum Mutat; 2005 May; 25(5):503-4. PubMed ID: 15841481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and clinical characteristics of maturity-onset diabetes of the young.
    Giuffrida FM; Reis AF
    Diabetes Obes Metab; 2005 Jul; 7(4):318-26. PubMed ID: 15955117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of eight novel glucokinase mutations in Italian children with maturity-onset diabetes of the young.
    Mantovani V; Salardi S; Cerreta V; Bastia D; Cenci M; Ragni L; Zucchini S; Parente R; Cicognani A
    Hum Mutat; 2003 Oct; 22(4):338. PubMed ID: 12955723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three novel missense mutations in the glucokinase gene (G80S; E221K; G227C) in Italian subjects with maturity-onset diabetes of the young (MODY). Mutations in brief no. 162. Online.
    Guazzini B; Gaffi D; Mainieri D; Multari G; Cordera R; Bertolini S; Pozza G; Meschi F; Barbetti F
    Hum Mutat; 1998; 12(2):136. PubMed ID: 10694920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review on monogenic diabetes.
    Steck AK; Winter WE
    Curr Opin Endocrinol Diabetes Obes; 2011 Aug; 18(4):252-8. PubMed ID: 21844708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maturity-onset diabetes of the young: clinical heterogeneity explained by genetic heterogeneity.
    Hattersley AT
    Diabet Med; 1998 Jan; 15(1):15-24. PubMed ID: 9472859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and clinical characteristics of Korean maturity-onset diabetes of the young (MODY) patients.
    Hwang JS; Shin CH; Yang SW; Jung SY; Huh N
    Diabetes Res Clin Pract; 2006 Oct; 74(1):75-81. PubMed ID: 16632067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel glucokinase gene mutation and its effect on glycemic/C-peptide fluctuations in a patient with maturity-onset diabetes of the young type 2.
    Loomba-Albrecht LA; Jame M; Bremer AA
    Diabetes Res Clin Pract; 2010 Mar; 87(3):e23-5. PubMed ID: 20015564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in GCK and HNF-1alpha explain the majority of cases with clinical diagnosis of MODY in Spain.
    Estalella I; Rica I; Perez de Nanclares G; Bilbao JR; Vazquez JA; San Pedro JI; Busturia MA; Castaño L;
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):538-46. PubMed ID: 17573900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.